Rider Michael J reported grant involving 3,230 shares of RESMED INC at $0.00 for $0 on Aug 14, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Global General Counsel
Global General Counsel
Filed Oct 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
3,230ResMed Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
12,718Direct
Trade date
Aug 14, 2026Grant
Filed
Oct 1, 2026, 4:23 PM ET48-day reporting delay
Accession
0000943819-26-000076Code A · Transaction 232908
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 48 calendar days after the transaction date.

RMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −10%1w ago −4.2%1d ago +2.5%
Returns since7d +2.5%30d +4%90d180d1y

Footnotes in full

F1: Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.